Back to Search
Start Over
PD-3 Phase 1 trial of vibostolimab plus pembrolizumab for PD-1/PD-L1 inhibitor-naive advanced gastric cancer: The KEYVIBE-001 trial
- Source :
- Annals of Oncology. 33:S240
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........31a5a52d2f7cceab7fd8b3fb3820cd2c
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.04.081